Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52‐Week , Randomized, Controlled Trial-Reference-Cited by-同舟云学术

Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52‐Week , Randomized, Controlled Trial

Published:2022-01-26 Issue: Volume: Page:
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Walsh Jessica A.¹^ORCID,Magrey Marina N.²,Baraliakos Xenofon³,Inui Kentaro⁴,Weng Meng‐Yu⁵,Lubrano Ennio⁶,Heijde Désirée⁷,Boonen Annelies⁸,Gensler Lianne S.⁹,Strand Vibeke¹⁰,Braun Jürgen³,Hunter Theresa¹¹^ORCID,Li Xiaoqi¹¹,Zhu Baojin¹¹,León Luis¹¹,Calderon David Marcelino Sandoval¹¹,Kiltz Uta³^ORCID

Affiliation:

1. University of Utah School of Medicine and Salt Lake City Veterans Affairs Medical Center Salt Lake City Utah

2. MetroHealth Medical Center and Case Western Reserve University School of Medicine Cleveland Ohio

3. Ruhr‐University Bochum Bochum, Germany, and Osaka City University Graduate School of Medicine Osaka Japan

4. Osaka City University Graduate School of Medicine Osaka Japan

5. National Cheng Kung University Medical College and Hospital Tainan Taiwan

6. University of Molise Campobasso Italy

7. Leiden University Medical Center Leiden The Netherlands

8. Maastricht University Medical Center and Caphri Research Institute Maastricht University Maastricht The Netherlands

9. University of California San Francisco

10. Stanford University School of Medicine Palo Alto California

11. Eli Lilly and Company Indianapolis Indiana